Additional Noteworthy Studies to be Presented During 2024 ASCO Quality Care Symposium

ALEXANDRIA, Va. - Five studies exploring a wide range of research will be presented at the upcoming 2024 American Society of Clinical Oncology (ASCO) Quality Care Symposium, taking place in taking place in San Francisco, California, and online, September 27-28. 

ASCO Experts are available to provide outside commentary and perspective on the studies below. Contact the ASCO Media Team to schedule an interview.

Abstract 377: Impact of real-world remote symptom monitoring program on hospitalizations and ICU admissions.
Abstract presentation part of session beginning at 1:00 PM (PT) on Friday, September 27.

Abstract 277: Development and validation of a risk prediction model for acute care use among patients with advanced cancer on clinical trials.
Abstract presentation part of session beginning at 1:00 PM (PT) on Friday, September 27.
"Hospitalizations and emergency room use is high among advanced cancer patients. Our goal was to develop a model to predict who was at highest risk for acute care use using data from patients enrolled in clinical trials. We found that about 67% of patients with advanced cancer enrolled on a clinical trial were hospitalized or went to an emergency room within a year after enrollment and that four factors were associated with significantly higher risk. About 58% of patients had at least two of these factors which resulted in a three-fold increased risk of acute care use. If we can easily identify elderly patients at the highest risk, we can more precisely target interventions for these patients to reduce risk," said lead study author Dawn L. Hershman, MD, MS, FASCO.

Abstract 4: Influence of an AYA cancer program on cancer care delivery.
Abstract presentation part of session beginning at 4:45 PM (PT) on Friday, September 27.
"These findings highlight the value of an AYA program to improving high quality care delivery for young adults with cancer. We know that teens and young adults face unique challenges in navigating a cancer diagnosis and treatment. UNC started a program to address those needs almost a decade ago; with our research here, we sought to describe the influence of that program on outcomes for these young patients with cancer. We saw that our program steadily expanded in the numbers of adolescent and young adult (AYA) patients served and that patients who connected with our program were more likely to receive guideline recommended cancer supportive care for AYAs than those who did not connect with our program. This included higher rates of clinical trial enrollment, fertility counseling, palliative care, and advanced care planning. We hope that our results encourage other centers to develop and grow AYA programs, and we hope to use these findings to develop an intervention that can more easily be shared and implemented at other cancer centers," said lead study author Jacob Newton Stein, MD, MPH.

Abstract 48: Molecular correlates of social adversity in breast cancer.
Abstract presentation part of session beginning at 9:45 AM (PT) on Saturday, September 28.

Abstract 45: Understanding health literacy's moderating role in remote monitoring for adjuvant endocrine therapy: Findings from a randomized clinical trial.
Abstract presentation part of session beginning at 1:45 PM (PT) on Saturday, September 28.
"Our findings suggest that targeted digital tools and personalized support could help individuals with lower health literacy better manage their treatment and potentially improve long-term health outcomes. People with lower health literacy, such as those who need help filling out medical forms, may struggle to read medication labels or manage side effects. This can lead to non-adherence to medication, such as adjuvant endocrine therapy (AET), a commonly recommended treatment to reduce breast cancer recurrence and improve survival. The THRIVE study tested if a mobile health app could help improve endocrine therapy adherence by monitoring symptoms and providing tailored educational messages. While the app did not impact overall 1-year adherence, this follow-up analysis revealed that women with lower health literacy who received the app and additional tailored text messages were more likely to stick to their AET than those in the control group," said lead study author Ilana Graetz, PhD.

View the News Planning Team disclosures: https://society.asco.org/sites/new-www.asco.org/files/content-files/about-asco/pdf/2024-QCS-NPT-Disclosures.pdf

ATTRIBUTION TO THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY QUALITY CARE SYMPOSIUM IS REQUESTED IN ALL COVERAGE. 
### 

Founded in 1964, the American Society of Clinical Oncology, Inc. (ASCO®) is committed to the principle that knowledge conquers cancer. Together with the Association for Clinical Oncology, ASCO represents more than 50,000 oncology professionals who care for people living with cancer. Through research, education, and promotion of high quality, equitable patient care, ASCO works to conquer cancer and create a world where cancer is prevented or cured, and every survivor is healthy. Conquer Cancer, the ASCO Foundation, supports ASCO by funding groundbreaking research and education across cancer's full continuum. Learn more at www.ASCO.org, and follow us on Facebook, X, LinkedIn, Instagram, and YouTube.